Oxmiq Labs Inc., a new GPU software and IP startup founded by Raja Koduri, has emerged from stealth mode after two years of development, boasting a team with over 500 years of combined experience in GPU and AI architecture.

On August 5, 2025, Oxmiq Labs announced the launch of licensable graphics processor technology designed for artificial intelligence data processing.

The company has chosen to focus on developing intellectual property rather than full chip designs to avoid the significant costs associated with chip development, which can exceed $500 million.

Oxmiq has successfully raised $20 million in seed funding from notable investors, including MediaTek, and has begun generating software revenue through a licensing-first model.

The company's software-first strategy promotes a unified stack for developers, highlighted by the launch of OXPython, which enables CUDA AI applications to run on non-NVIDIA hardware.

Oxmiq's innovative architecture includes a modular core and chiplet-based design, allowing for scalable solutions from edge devices to zettascale data centers.

The startup is well-positioned to capitalize on macro trends such as the AI compute bottleneck and the rise of AI-as-a-service, creating opportunities for emerging markets to establish AI infrastructure.

Oxmiq's mission is to reinvent GPU architecture for the multimodal AI era, integrating various data types such as text, audio, video, images, and 3D environments.

Koduri expressed his ambition for Oxmiq to become the equivalent of Arm for the next generation of GPU technology, fostering a more competitive environment in AI hardware development.

The design includes chiplets referred to as MCBs and CCBs, which are complete systems-on-chip (SoCs) aimed at data centers rather than consumer gaming PCs.

Key performance indicators for investors will include the adoption rate of OXPython in enterprises and Oxmiq's IP licensing revenue per core, reflecting the viability of its business model.

Raja Koduri has stepped back from day-to-day operations at Mihira, a company he co-founded, to concentrate on Oxmiq, while still maintaining a minority stake.